Compare ALEC & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALEC | MFM |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.4M | 219.3M |
| IPO Year | 2019 | N/A |
| Metric | ALEC | MFM |
|---|---|---|
| Price | $1.51 | $5.51 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 703.1K | 204.0K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | $183.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $5.03 |
| 52 Week High | $3.40 | $5.67 |
| Indicator | ALEC | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 61.78 |
| Support Level | $1.14 | $5.48 |
| Resistance Level | $1.60 | $5.58 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 10.71 | 48.33 |
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.